These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 9207967)
1. [Value of scintigraphic explorations by radiomarkers others than iodine radioisotope in differentiated thyroid cancer]. Sassolas G; Houzard C; Sigartau C; Borson-Chazot F Ann Endocrinol (Paris); 1997; 58(1):55-63. PubMed ID: 9207967 [TBL] [Abstract][Full Text] [Related]
2. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy. Lind P; Gallowitsch HJ Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519 [TBL] [Abstract][Full Text] [Related]
3. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma. Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Gomez I; Lind P J Nucl Med; 1998 May; 39(5):870-5. PubMed ID: 9591591 [TBL] [Abstract][Full Text] [Related]
4. Value of combined technetium-99m hydroxy methylene diphosphonate and thallium-201 imaging in detecting bone metastases from thyroid carcinoma. Alam MS; Takeuchi R; Kasagi K; Misaki T; Miyamoto S; Iida Y; Hidaka A; Konishi J Thyroid; 1997 Oct; 7(5):705-12. PubMed ID: 9349573 [TBL] [Abstract][Full Text] [Related]
5. Tc-99m MIBI scintigraphy in tall cell variant of papillary thyroid carcinoma with negative radioiodine scan. Kaya M; Cermik TF Clin Nucl Med; 2008 Sep; 33(9):615-8. PubMed ID: 18716510 [TBL] [Abstract][Full Text] [Related]
6. Isotope imaging for metastatic thyroid cancer. Haugen BR; Lin EC Endocrinol Metab Clin North Am; 2001 Jun; 30(2):469-92. PubMed ID: 11444171 [TBL] [Abstract][Full Text] [Related]
7. Indium-111-Octreotide scintigraphy in differentiated thyroid carcinoma metastases that do not respond to treatment with high-dose I-131. Stokkel MP; Reigman HI; Verkooijen RB; Smit JW J Cancer Res Clin Oncol; 2003 May; 129(5):287-94. PubMed ID: 12750997 [TBL] [Abstract][Full Text] [Related]
8. Comparison of 99mTc-methoxyisobutyl isonitrile and 201Tl scintigraphy for detection of residual thyroid cancer after 131I ablative therapy. Seabold JE; Gurll N; Schurrer ME; Aktay R; Kirchner PT J Nucl Med; 1999 Sep; 40(9):1434-40. PubMed ID: 10492361 [TBL] [Abstract][Full Text] [Related]
9. Fluorine-18-FDG and iodine-131-iodide uptake in thyroid cancer. Feine U; Lietzenmayer R; Hanke JP; Held J; Wöhrle H; Müller-Schauenburg W J Nucl Med; 1996 Sep; 37(9):1468-72. PubMed ID: 8790195 [TBL] [Abstract][Full Text] [Related]
10. [Evaluation of technetium-99m-MIBI scintigraphy in metastatic differentiated thyroid cancer--comparison study with 131I and 201Tl]. Nagamachi S; Jinnouchi S; Nishii R; Flores LG; Nakahara H; Futami S; Tamura S; Toshimori H; Kawai K Kaku Igaku; 2000 Mar; 37(2):89-98. PubMed ID: 10783567 [TBL] [Abstract][Full Text] [Related]
11. Follow-up of differentiated thyroid cancer: what is the value of FDG and sestamibi in the diagnostic algorithm? Dietlein M; Scheidhauer K; Voth E; Theissen P; Schicha H Nuklearmedizin; 1998 Jan; 37(1):12-7. PubMed ID: 9467164 [TBL] [Abstract][Full Text] [Related]
12. Whole-body scintigraphy with 99Tcm-MIBI, 18F-FDG and 131I in patients with metastatic thyroid carcinoma. Fridrich L; Messa C; Landoni C; Lucignani G; Moncayo R; Kendler D; Riccabona G; Fazio F Nucl Med Commun; 1997 Jan; 18(1):3-9. PubMed ID: 9061694 [TBL] [Abstract][Full Text] [Related]
13. [Complementary scintigraphic examinations (99mTc-MDP, 99mTc-MIBI and Octreoscan) in breast neoplasm assessment]. Stefănescu C; Chossiere L; Rusu V; Meignan M Rev Med Chir Soc Med Nat Iasi; 1996; 100(3-4):165-8. PubMed ID: 9455458 [TBL] [Abstract][Full Text] [Related]
14. Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan. Chung JK; So Y; Lee JS; Choi CW; Lim SM; Lee DS; Hong SW; Youn YK; Lee MC; Cho BY J Nucl Med; 1999 Jun; 40(6):986-92. PubMed ID: 10452315 [TBL] [Abstract][Full Text] [Related]
15. Imaging of metastases of thyroid carcinoma with fluorine-18 fluorodeoxyglucose. Joensuu H; Ahonen A J Nucl Med; 1987 May; 28(5):910-4. PubMed ID: 3572549 [TBL] [Abstract][Full Text] [Related]
16. Thallium-201, technetium-99m-tetrofosmin and iodine-131 in detecting differentiated thyroid carcinoma metastases. Unal S; Menda Y; Adalet I; Boztepe H; Ozbey N; Alagöl F; Cantez S J Nucl Med; 1998 Nov; 39(11):1897-902. PubMed ID: 9829579 [TBL] [Abstract][Full Text] [Related]
17. Detection of residual and recurrent thyroid cancer by radionuclide imaging. Maxon HR Thyroid; 1999 May; 9(5):443-6. PubMed ID: 10365674 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of technetium-99m methoxyisobutyl isonitrile (99mTc-MIBI) scintigraphy in detecting thyroid cancer metastases: a critical evaluation. Alam MS; Kasagi K; Misaki T; Miyamoto S; Iwata M; Iida Y; Konishi J Thyroid; 1998 Dec; 8(12):1091-100. PubMed ID: 9920363 [TBL] [Abstract][Full Text] [Related]